Clinical Trials Logo

Pneumonia clinical trials

View clinical trials related to Pneumonia.

Filter by:

NCT ID: NCT05197686 Not yet recruiting - Clinical trials for Corona Virus Infection

Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.

Start date: January 18, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to compare two methods of oxygen therapy in patients with acute respiratory distress syndrome in the course of SARS-CoV2 pneumonia. The initial method of oxygen supply during coronavirus pneumonia is conventional oxygen therapy using a face mask or nasal cannula. However, there have been reports in the literature that early initiation of high-flow oxygen therapy with a nasal cannula is associated with better prognosis. The study we perform is intended to provide reliable evidence for confirmation this hypothesis.

NCT ID: NCT05174741 Not yet recruiting - Asthma Clinical Trials

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Start date: April 2023
Phase: N/A
Study type: Interventional

To determine the effect of pulmonary rehabilitation on pulmonary function in non-chronic obstructive pulmonary disease patients.To determine the effect of pulmonary rehabilitation on health related quality of life in non-chronic obstructive pulmonary disease patients.Limited researches are available in non chronic obstructive pulmonary disease patients.

NCT ID: NCT05171985 Not yet recruiting - Atrial Fibrillation Clinical Trials

Dexmedetomidine Reduces Atrial Fibrillation in Mechanically Ventilated Patients With COVID-19 Pneumonia

Start date: January 2022
Phase: N/A
Study type: Interventional

Coronavirus disease 2019 (COVID-19) is a novel, has rapid spread worldwide. Currently, almost 11 million cases have been diagnosed and more than 500,000 infected people have died rather than undiagnosed patients . Although COVID-19 is mostly characterized by the respiratory tract affection, cardiovascular complications frequently accompany COVID-19 infections increasing morbidity and mortality in such patients . Arrhythmias are frequently reported in COVID-19 patients, with atrial fibrillation (AF) being the most common form . Although electrical, calcium handling, and structural remodeling plays a key role in AF pathophysiology , the clinical presentation of AF is diverse and the precise mechanisms of AF remain unclear in this large proportion of patients . In patients with severe pneumonia, acute respiratory distress syndrome (ARDS) and sepsis, the incidence of AF during hospitalization is usually high . For instance, about 23-33% of critically ill patients with sepsis or ARDS have AF recurrences and 10% develop de novo AF. Dexmedetomidine preserves the natural sleep pattern and induces cooperative sedation in which patients are easily arousable, leading to to less impairment in cognitive function. In addition, it has an opioid sparing effect, and it is associated with a significant decrease in the duration of delirium, ventilatory care along with ICU stay, and therefore it is associated with a significant improvement in outcomes. These mentioned advantages make dexmedetomidine a fundamental sedative in ICU practice . The use of dexmedetomidine to prevent atrial fibrillation is unclear . However, two retrospective studies also showed that dexmedetomidine sedation might

NCT ID: NCT05143593 Not yet recruiting - Severe Pneumonia Clinical Trials

Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This study is a multicenter randomized controlled trial. The purpose of this study is to assess the efficacy of the combination of PCR and CRISPR/Cas12a (SSBD)in tract secretion from lower respiratory for early targeted anti-infective therapy for patients with severe pneumonia. 5 adult ICU units from 5 hospitals in Jiangsu province participate the study and the hosted unit is the Department of Critical Care Medicine, Affiliated Drum Tower Hospital of Nanjing University Medical College. All patients are randomly assigned to the experiment group and the control group. For experiment group, the combined detection of PCR andCRISPR/Cas12a is carried out in the early stage, and the antibiotic scheme is changed base on the results of PCR-CRISPR/Cas12a. The patients in the control group are adjusted according to the traditional microbial detection methods. Some clinical parameters and outcomes are recorded.

NCT ID: NCT05140720 Not yet recruiting - Clinical trials for Vaccine Preventable Disease

Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age

PNEUMOSIL
Start date: January 25, 2022
Phase: N/A
Study type: Interventional

The current study provides data necessary to evaluate the safety and immunogenicity of Serum Institute of India's PNEUMOSIL® [Pneumococcal Polysaccharide Conjugate Vaccine Adsorbed (10-Valent)] in Healthy Vietnamese Infants and Toddlers, 6 weeks to 24 months of age. This is an open label, prospective, bridging study.

NCT ID: NCT05092555 Not yet recruiting - COVID-19 Pneumonia Clinical Trials

Clinical Presentations and Outcomes of Patients With Covid-19 Pneumonia

Start date: November 1, 2021
Phase:
Study type: Observational

This study aims at determining clinical presentations and outcomes of patients with covid-19 pneumonia and also follow up of patients for up to 6 months to detect possibility of post covid fibrosis

NCT ID: NCT05050851 Not yet recruiting - Clinical trials for Anemia, Iron Deficiency

Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt

Start date: September 30, 2021
Phase:
Study type: Observational

Decrease mortality rate resulting from pneumonia

NCT ID: NCT05017519 Not yet recruiting - Clinical trials for Respiratory Syncytial Virus Infections

Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus

Start date: October 1, 2021
Phase:
Study type: Observational [Patient Registry]

This household-based prospective cohort study aims to stablish the household transmission of Respiratory syncytial virus and S. pneumoniae especially in the elderly and infants/children as well as inter-relationship between S. pneumoniae and Respiratory syncytial virus.

NCT ID: NCT04955704 Not yet recruiting - Pneumonia Clinical Trials

Performance Study for InferRead CT Pneumonia.AI

Start date: September 1, 2021
Phase:
Study type: Observational

A retrospective, blineded, multicenter study of the InferRead CT Pneumonia.AI to evaluate the performance in identifying non-contrast chest CT scans containing pneumonia findings.

NCT ID: NCT04955223 Not yet recruiting - Viral Pneumonia Clinical Trials

Yinhu Qingwen Granule in the Treatment of Viral Pneumonia

Start date: December 2022
Phase: Early Phase 1
Study type: Interventional

This is a non-randomized single arm clinical study to observe the effect of Yinhu Qingwen Granule in the relief of fever and improvement of related-symptoms of patients with viral pneumonia.